Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Acute Lymphoblastic Leukemia
3:52
Outcomes of children and young adults with B-ALL following tisa-cel reinfusion
Kevin McNerney
• 24 Feb 2023
8:25
CAR-T therapy in acute and chronic leukemias: current applications and future outlooks
John Gribben
• 10 Feb 2023
2:21
Exploring the potential role of CD7-targeting CAR-T cells in T-ALL
Maksim Mamonkin
• 10 Feb 2023
2:20
Overcoming barriers in treating liquid tumors with T-cell therapies
Michela Consonni
• 1 Apr 2022
3:07
Horizon scanning in anti-CD19 CAR T-cell therapy
Marco Alessandrini
• 20 May 2021
4:13
CAR T-cells in adult ALL
Arnon Nagler
• 1 Feb 2021
4:31
Novel strategies to optimize CAR T-cell therapy
Arnon Nagler
• 1 Feb 2021
2:19
Progression of CAR-T trials in China
Jianxiang Wang
• 2 Feb 2021
3:21
CAR-T trials to watch in China
Jianxiang Wang
• 2 Feb 2021
3:30
Second CD19-targeted CAR T-cell infusion for R/R B-cell malignancies
Jordan Gauthier
• 28 Jan 2021
6:09
CAR-T vs. BiTEs in B-cell malignancies
Marion Subklewe
• 11 Feb 2021
3:11
ARI-0001 CART19 cells in R/R B-ALL with isolated extramedullary disease
Valentín Ortiz-Maldonado
• 3 Feb 2021
1:12
ARI-0001 in CD19+ malignancies: next steps
Valentín Ortiz-Maldonado
• 3 Feb 2021
4:18
The challenges of CAR T-cell therapy for pediatric B-ALL
Sara Ghorashian
• 4 Feb 2021
8:17
CART19-BE-01: ARI-0001 in CD19+ malignancies
Valentín Ortiz-Maldonado
• 11 Oct 2020
4:51
Anti-CD19 CAR T-cells for adults
David L. Porter
• 9 Sep 2020
1
2
Next
